本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Immunocore Holdings plc

30.46
+0.31001.03%
盤後30.460.00000.00%16:06 EDT
成交量:13.33萬
成交額:409.32萬
市值:15.25億
市盈率:-29.81
高:31.38
開:30.22
低:30.22
收:30.15
資料載入中...
2024/01/02

重要事件披露

Form 8-K - Current report
2023/12/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/19

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/16

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/08

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/04/19

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/04/17

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/04/17

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/04/06

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/01

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals